ImprimisRx® Announces Exclusive Agreement with Doxy.me to Provide Healthcare Professionals with Telemedicine Services
March 24, 2020 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., March 24, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) and ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding...
Harrow Health Appoints Teresa Sparks to its Board of Directors
March 17, 2020 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., March 17, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced the appointment of Teresa Sparks to its Board of Directors. Mark L. Baum, CEO of Harrow...
Harrow Health Publishes Fourth Quarter 2019 Letter to Stockholders
March 13, 2020 07:31 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., March 13, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the fourth quarter 2019. Please click here to review Harrow Health’s Letter to...
ImprimisRx® Announces Supply Agreement with EyeCare Services Partners
March 12, 2020 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, March 12, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of...
ImprimisRx® Announces Supply Agreement with iOR Partners
March 09, 2020 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, March 09, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of...
ImprimisRx® Announces Supply Agreement with Vision Center Network of America (VCNA)
March 03, 2020 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, March 03, 2020 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, and a wholly-owned subsidiary of...
Harrow Health to Announce Fourth Quarter 2019 Financial Results on March 13, 2020
February 27, 2020 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Feb. 27, 2020 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that before the open of trading on Friday, March 13, 2020, it will release fourth quarter 2019...
ImprimisRx’s FDA-Registered Outsourcing Facility Issued California License
December 10, 2019 07:30 ET
|
Harrow Health, Inc.
SAN DIEGO, Dec. 10, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the nation’s leading ophthalmic-focused outsourcing facility and pharmaceutical compounding business, a wholly-owned subsidiary of Harrow...
Harrow Health Publishes Third Quarter Letter to Stockholders
November 13, 2019 16:03 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Nov. 13, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today reported results for the third quarter 2019. Please click here to review Harrow Health’s complementary...
Harrow Health to Announce Third Quarter 2019 Financial Results on November 13, 2019
October 24, 2019 07:30 ET
|
Harrow Health, Inc.
NASHVILLE, Tenn., Oct. 24, 2019 (GLOBE NEWSWIRE) -- Harrow Health, Inc. (NASDAQ: HROW) today announced that after the close of trading on Wednesday, November 13, 2019, it will release third quarter...